Entropy Technologies LP raised its position in The Clorox Company (NYSE:CLX – Free Report) by 86.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,743 shares of the company’s stock after acquiring an additional 5,918 shares during the period. Entropy Technologies LP’s holdings in Clorox were worth $2,070,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Brooklyn Investment Group boosted its position in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new stake in Clorox in the third quarter valued at about $27,000. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new stake in Clorox in the third quarter worth about $48,000. Finally, Friedenthal Financial purchased a new stake in shares of Clorox during the third quarter worth about $49,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of analysts recently commented on the stock. Wells Fargo & Company lifted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus target price of $158.21.
Clorox Trading Up 0.6 %
Shares of NYSE:CLX opened at $148.51 on Monday. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The business has a 50 day moving average of $161.06 and a two-hundred day moving average of $158.88. The company has a market capitalization of $18.38 billion, a PE ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm earned $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- There Are Different Types of Stock To Invest In
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Options Trading – Understanding Strike Price
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- The Most Important Warren Buffett Stock for Investors: His Own
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.